Search results

Search list

Results in:

1-10 of 743 results
Standards [CURRENT]

DIN EN 13641

Elimination or reduction of risk of infection related to in vitro diagnostic reagents; German version EN 13641:2002, German and English texts
Edition 2002-08

Standards [CURRENT]

DIN EN ISO 22442-3

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007); German version EN ISO 22442-3:2007
Edition 2008-03

Standards [CURRENT]

ISO/IEC/IEEE 8802-1CB

Information technology - Telecommunications and information exchange between systems - Local and metropolitan area networks - Specific requirements - Part 1CB: Frame replicaton and elimination for reliability
Edition 2019-02

Standards [CURRENT]

ISO 22442-3

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Edition 2007-12

Standards [CURRENT]

OENORM EN ISO 22442-3

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007)
Edition 2008-04-01

Standards [CURRENT]

OENORM EN 13641

Elimination or reduction of risk of infection related to in vitro diagnostic reagents
Edition 2002-07-01

Standards [CURRENT]

SN EN ISO 22442-3

Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents (ISO 22442-3:2007)
Edition 2008-03

Standards [CURRENT]

SN EN 13641

Elimination or reduction of risk of infection related to in vitro diagnostic reagents
Edition 2002-05

Elimination or reduction of risk of infection related to in vitro diagnostic reagents
Edition 2002-10-01

Medical devices utilizing animal tissues and their derivatives - Part 3: validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Edition 2008-03-01

TOP